Forward Look

Treatments for small cell lung cancer have remained virtually the same for decades. Now, experts say that hope is on the horizon.

by Isobel Whitcomb

9/11 first responders' cancer survival compares favorably to the general population, and a study identifies different mutational signatures in lung cancers from never-smokers

by Marci A. Landsmann

A drug that delivers radioactive particles to prostate cancer cells increases overall survival for metastatic castration-resistant prostate cancer.

by Pamela Rafalow Grossman

Regular exercise can help mitigate cognitive problems associated with chemotherapy, and researchers learn more about the link between cholesterol and cancer.

by Bradley Jones

Patient volume at radiation therapy clinics can affect outcomes, and experts call attention to a third breast cancer gene, PALB2.

by Marci A. Landsmann

Survival is not affected by delaying breast cancer treatment for fertility preservation, and the FDA approves a drug combination to treat kidney cancer.

by Kevin McLaughlin

People who have inherited BRCA mutations and are at high risk for cancer recurrence may benefit from a PARP inhibitor.

by Pamela Rafalow Grossman

Healthy lifestyle habits can reduce risk of cancer, and less treatment may be adequate for some children with ALL.

by Marci A. Landsmann

Two studies on access to opioids identify disturbing patterns, and Keytruda before and after surgery helps some breast cancer patients.

by Kevin McLaughlin

After adapting remote patient monitoring programs to cancer patients with COVID-19, cancer centers delve deeper into the programs' value for cancer patients undergoing treatment.

by Jon Kelvey